Dubai: Dubai Airport Free Zone, home to multinational pharmaceutical companies in the UAE, is taking part in the largest Pharmaceutical and Biotechnology event (Pharmaceutical & Biotechnology Middle East) PABME 2009 at Dubai International Convention and Exhibition Center from April 20-22.
Mr Ibrahim Ahli, Marketing Director Dubai Airport Free Zone, said 'It is the first time that we've exhibited in PABME 2009 and we're definitely looking forward to expand on our sales and marketing activities.
PABME estimates that pharmaceutical sales revenue in the markets of North Africa, The Levant States and Iran as well as the newer markets of the GCC countries (Saudi Arabia, Kuwait, Bahrain, Oman, Qatar and the UAE): combined these markets are valued at over AED 44 billion (US$12 billion) and are estimated to be growing at an annual rate of over 10%.
Research has further shown that in the Middle East there is an estimated to be over 450 pharmaceutical manufacturers - a figure that is growing dramatically year on year. "This is a market that the Freezone is keen to attract," said Mr. Ahli.
Dubai Airport Free Zone has been participating in quite a number of specialised exhibitions which help the free zone attract multinational companies.
Mr. Ahli added, "PABME 2009 is an exciting stage to network and discuss business. "Our strategy in PABME 2009 is to increase our opportunities to attract and communicate with pharmaceutical companies to set up offices and invest in the Middle East in general and the UAE in particular..."
'The pharmaceutical and biotechnology sectors are growing at such an incredible rate in the region. Several international companies are participating in this large event that it would give us a chance to meet the market leaders and new investors across the globe."
"Sales department representatives at the free zone will be present at the stand to address visitors inquiries and needs with all information and data that would be of interest to pharmaceutical and biotechnological companies," said Mr. Ahli
No comments:
Post a Comment